A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients.

Kuemmel, Sherko; Heil, Joerg; Rueland, Anna; Seiberling, Christine; Harrach, Hakima; Schindowski, Dorothea; Lubitz, Juliane; Hellerhoff, Karin; Ankel, Christine; Graßhoff, Sven-Thomas; Deuschle, Petra; Hanf, Volker; Belke, Kerstin; Dall, Peter; Dorn, Julia; Kaltenecker, Gabriele; Kuehn, Thorsten; Beckmann, Ulrike; Potenberg, Jochem; Blohmer, Jens-Uwe; Kostara, Athina; Breit, Elisabeth; Holtschmidt, Johannes; Traut, Eugen; Reinisch, Mattea

doi:10.1097/SLA.0000000000004572

Public

A Prospective, Multicenter Registry Study to Evaluate the Clinical Feasibility of Targeted Axillary Dissection (TAD) in Node-positive Breast Cancer Patients.

Shared by NobleBlocks on Nov 1, 2022 • 12:00 AM UTC

Authors:

Sherko Kuemmel

Joerg Heil

Anna Rueland

Abstract

OBJECTIVE: This study aimed to investigate the feasibility and accuracy of non-radioactive TLN biopsy and TAD in routine clinical practice. BACKGROUND DATA: TAD involves TLN biopsy (TLNB) and sentinel lymph node biopsy and was recently introduced as a new standard for less invasive axillary staging ...

Discussions